Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS) (PROMISSE)
First filed Sept. 2005, updated July 2020 - Recruiting
The PROMISSE Study is a prospective observational study that will follow 700 pregnant patients who will be grouped and analyzed according to the presence or absence of aPL antibodies and preexisting SLE. The data obtained will be analyzed and used to explore mechanisms and predictors of poor fetal outcome.
To Learn More Contact
Marta M. Guerra, MS 212-774-7361 or firstname.lastname@example.org
Elianna Kaplowitz, AB at 212-774-7614 or email@example.com
ClinicalTrials.gov identifier: NCT00198068